back

April 23, 2018

Kissei Announces New President and COO

Kissei Pharmaceutical Co., Ltd.



At the meeting of our Company's Board of Directors on April 23, 2018, a decision was made to change the President as follows.

This change will be authorized at the regular shareholders' meeting and at the meeting of Board of Directors, both scheduled for June 27, 2018.




1.Reason for Change

Kissei reviews management structure to challenge to responding some issues arising from change of the business environment.



2.New Roles

New Title Name Current Title
President and COO Yoshio Furihata Managing Director,

Member of the board,

Head of Clinical Development Division

Member of the board,

Director, Adviser

Masaki Morozumi President and COO



3.Resume of the new President

Name Resume Shares held
Yoshio Furihata

(DOB:

 January 12, 1962)

April 1984  Joined the Company

October 2000 Representative of Kissei Pharma Europe, Ltd.

April 2007  Director of Business Development

June 2008  Member of the board,
        Director of Business Development

June 2010  Member of the board,
        Director of Corporate Strategy and Planning Department

June 2012  Member of the board,
        Head of Clinical Development Division

June 2016  Managing Director,
        Member of the board,
        Head of Clinical Development Division
        (to the present)

8,200shares



4.Effective date: June 27, 2018